TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32594766

Group type: EXPERIMENTAL
Intervention: LDL-C target of <70 mg/dL
Number of subjects: 413

Group type: COMPARATOR
Intervention: LDL-C target of 100±10 mg/dL
Number of subjects: 413
Study: 33148134

Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Mobilization
Number of subjects: 45
Study: 32423275

Group type: EXPERIMENTAL
Intervention: Epinephrine HFA (Primatene® MIST)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Epinephrine CFC (Primatene® MIST CFC)
Number of subjects: 23
Study: 36060654

Group type: EXPERIMENTAL
Intervention: Carboprost aminobutyriol combined with oxytocin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 120
Study: 33774942

Group type: EXPERIMENTAL
Intervention: Topical ozonated sunflower oil (950 peroxide value) applied daily for one week
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-ozonated sunflower oil (control) applied daily for one week
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Topical ozonated sunflower oil
Number of subjects: 36
Study: 34772441

Group type: EXPERIMENTAL
Intervention: Oral antibiotic treatment after 2 weeks of IV antibiotic therapy
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard 6-8 weeks of IV antibiotics
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Oral antibiotic treatment
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard IV antibiotics
Number of subjects: 450
Study: 32466190

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels classified as light, moderate, vigorous
Number of subjects: 6875

Group type: EXPERIMENTAL
Intervention: Higher Body Mass Index (BMI)
Number of subjects: 6875

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 6875
Study: 35079029

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (INI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal insulin (INI) and Placebo
Number of subjects: 0
Study: 32737613

Group type: EXPERIMENTAL
Intervention: 2% fat milk
Number of subjects: 44

Group type: COMPARATOR
Intervention: apple juice
Number of subjects: 44

Group type: COMPARATOR
Intervention: water
Number of subjects: 44
Study: 34416060

Group type: EXPERIMENTAL
Intervention: FPE-D (fermented pomegranate extract drink)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: FPE-S (fermented pomegranate extract serum)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo serum
Number of subjects: 80
Study: 34509600

Group type: EXPERIMENTAL
Intervention: l-glutamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 35600633

Group type: EXPERIMENTAL
Intervention: AYUSH 64 (3 gm per day in three divided doses for 14 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard of Care (SOC) alone
Number of subjects: 80
Study: 33471548

Group type: EXPERIMENTAL
Intervention: Focal boost arm (95 Gy, fractions up to 2.7 Gy)
Number of subjects: 571

Group type: COMPARATOR
Intervention: Standard treatment arm (77 Gy, fractions of 2.2 Gy)
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Focal boost arm
Number of subjects: 571

Group type: COMPARATOR
Intervention: Standard treatment arm
Number of subjects: 571

Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Focal boost arm and Standard arm
Number of subjects: 571
Study: 36213585

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 272

Group type: COMPARATOR
Intervention: Traditional open surgery
Number of subjects: 272
Study: 34407771

Group type: EXPERIMENTAL
Intervention: Digital intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 103

Group type: COMPARATOR
Intervention: Digital intervention and Treatment as usual
Number of subjects: 103
Study: 34704605

Group type: EXPERIMENTAL
Intervention: Neural Network (NN)
Number of subjects: 17793

Group type: COMPARATOR
Intervention: Logistic Regression (LR)
Number of subjects: 17793
Study: 32192275

Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg intravenously) combined with Aprepitant (125 mg orally, D1 and 80 mg orally, D2-3) and Dexamethasone (12 mg orally or intravenously, D1 and 8 mg orally, D2-4)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Palonosetron (0.25 mg intravenously) combined with Aprepitant (125 mg orally, D1 and 80 mg orally, D2-3) and Dexamethasone (12 mg orally or intravenously, D1 and 8 mg orally, D2-4)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Ramosetron (RAD)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Palonosetron (PAD)
Number of subjects: 279
Study: 35296183

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise for 48 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise
Number of subjects: 84
Study: 33419188

Group type: EXPERIMENTAL
Intervention: TNT (CRT followed by three cycles of CAPOX)
Number of subjects: 197

Group type: COMPARATOR
Intervention: CRT (50 Gy with oral capecitabine)
Number of subjects: 197
Study: 32342143

Group type: EXPERIMENTAL
Intervention: Computer-assisted PAO
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional PAO
Number of subjects: 91
Study: 35612708

Group type: EXPERIMENTAL
Intervention: Finerenone 20 mg with high-fat, high-calorie meal
Number of subjects: 81

Group type: COMPARATOR
Intervention: Finerenone 10 mg with omeprazole
Number of subjects: 81

Group type: COMPARATOR
Intervention: Finerenone 10 mg with Maalox
Number of subjects: 81
Study: 34002953

Group type: EXPERIMENTAL
Intervention: Treatment with pioglitazone plus exenatide or insulin
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Individuals with homeostasis model assessment of IR <1.9
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Individuals with homeostasis model assessment of IR ≥1.9
Number of subjects: 38
Study: 32044174

Group type: EXPERIMENTAL
Intervention: Clinically used bilayer collagen membrane with fibrin glue (Chondro‐Gide)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Trilayer collagen prototype without fibrin glue
Number of subjects: 11
Study: 36315955

Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin + ezetimibe
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-intensity statin alone
Number of subjects: 0
Study: 33091455

Group type: EXPERIMENTAL
Intervention: Nonsurgical endodontic treatment (NSET)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonsurgical endodontic treatment (NSET) combined with vital pulp therapy (VPT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSET and VPT
Number of subjects: 60
Study: 32563188

Group type: EXPERIMENTAL
Intervention: Dual trigger (GnRH agonist and hCG)
Number of subjects: 155

Group type: COMPARATOR
Intervention: hCG trigger
Number of subjects: 155
Study: 35555189

Group type: EXPERIMENTAL
Intervention: Creatine Nitrate (CN: 5 g/day + 0.675 g/day of maltodextrin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF: 400 mg/day + 5 g/day of maltodextrin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Creatine Nitrate + Caffeine (CN+CAF: 5 g/day of creatine nitrate + 400 mg/day of caffeine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PL: 5.4 g/day of maltodextrin)
Number of subjects: 12
Study: 37723993

Group type: EXPERIMENTAL
Intervention: Oral sildenafil citrate, administered after onset of labor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 33248439

Group type: EXPERIMENTAL
Intervention: Menthol energy gel (0.5% concentration)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Menthol energy gel (0.1% concentration)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mint-flavored placebo (CON)
Number of subjects: 40
Study: 33172865

Group type: EXPERIMENTAL
Intervention: Teprotumumab treatment for 24 weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non-TED control group
Number of subjects: 6
Study: 32989632

Group type: EXPERIMENTAL
Intervention: Free Androgen Index (FAI)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Free Testosterone (FT)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Total Testosterone (TT)
Number of subjects: 1000
Study: 36437811

Group type: EXPERIMENTAL
Intervention: Test yoghurt (Lactiplantibacillus plantarum Inducia)
Number of subjects: 240
Study: 34929814

Group type: EXPERIMENTAL
Intervention: Moringa oleifera leaf capsules
Number of subjects: 75

Group type: COMPARATOR
Intervention: TTD capsules
Number of subjects: 75
Study: 32745733

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with SAPIEN 3 or SAPIEN 3 Ultra device
Number of subjects: 440

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 440

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 440
Study: 35546289

Group type: EXPERIMENTAL
Intervention: Integrated Care Pathway (ICP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group without dementia (n = 17)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group without dementia (n = 36)
Number of subjects: 28
Study: 34088340

Group type: EXPERIMENTAL
Intervention: Use of NSAIDs
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Not meeting physical activity guidelines
Number of subjects: 605
Study: 32741328

Group type: EXPERIMENTAL
Intervention: SAPP plus perturbation training (n = 19)
Number of subjects: 39

Group type: COMPARATOR
Intervention: SAPP (n = 20)
Number of subjects: 39
Study: 35915452

Group type: EXPERIMENTAL
Intervention: Standard-of-care methods in addition to rapid molecular testing using the BioFire® FilmArray® Pneumonia Panel plus (FAP plus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard microbiological testing (control group)
Number of subjects: 0
Study: 32907566

Group type: EXPERIMENTAL
Intervention: Navafenterol 400 μg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Navafenterol 1800 μg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Indacaterol 150 μg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Tiotropium 18 μg
Number of subjects: 38
Study: 35514033

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting lung cancer-specific survival (LCSS) and overall survival (OS) in the training cohort.
Number of subjects: 9584

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting LCSS and OS in elderly patients with metastatic NSCLC.
Number of subjects: 9584

Group type: COMPARATOR
Intervention: Nomograms for predicting LCSS and OS compared to TNM staging models.
Number of subjects: 9584
Study: 34111867

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 18
Study: 36343472

Group type: EXPERIMENTAL
Intervention: Automated virtual reality therapy (gameChange)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 345
Study: 32001075

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied to bilateral deltoid and quadriceps femoris muscles with 50 Hz for 3 days/week, 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 0
Study: 34621143

Group type: EXPERIMENTAL
Intervention: 3D laparoscopy
Number of subjects: 158
Study: 33164850

Group type: EXPERIMENTAL
Intervention: Exercise before exposure for 20 min (Before Only, BO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise after exposure for 20 min (After Only, AO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise before and after exposure for 10 min at each time (Before and After, BA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-exercise Control (NC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of BA condition to NC condition in Study Two
Number of subjects: 0
Study: 35647942

Group type: EXPERIMENTAL
Intervention: IHMs plus any one of the following MTs: Cephalandra indica, Gymnema sylvestre, and Syzygium jambolanum (experimental)
Number of subjects: 89

Group type: COMPARATOR
Intervention: IHMs only (control)
Number of subjects: 89
Study: 33231847

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy group intervention (8 sessions)
Number of subjects: 76
Study: 32731748

Group type: EXPERIMENTAL
Intervention: NDBI-Fi measure
Number of subjects: 0
Study: 36093920

Group type: EXPERIMENTAL
Intervention: Adalimumab adjunct to sertraline
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo adjunct to sertraline
Number of subjects: 36
Study: 32030691

Group type: EXPERIMENTAL
Intervention: Patient Perspective Questionnaire (PPQ)
Number of subjects: 350
Study: 34893436

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (scratch group)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Sham procedure (sham group)
Number of subjects: 117
Study: 36214182

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention via videoconference (n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Unguided training via podcasts (n=25)
Number of subjects: 50
Study: 34162962

Group type: EXPERIMENTAL
Intervention: Bright light exposure (2500 lx)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Dim light exposure (<50 lx)
Number of subjects: 21
Study: 32360313

Group type: EXPERIMENTAL
Intervention: NACP on the base formulation (with 20 wt.% NACP)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: NACP on the antibacterial formulation (with 20 wt.% NACP and 5 wt.% DMAHDM)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Base formulation (without NACP and DMAHDM)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Negative control (without sealant application)
Number of subjects: 4
Study: 35438671

Group type: EXPERIMENTAL
Intervention: NLTX (50 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 14
Study: 36394651

Group type: EXPERIMENTAL
Intervention: Low concentration of lidocaine (group B)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High concentration of lidocaine (group C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 48
Study: 34398009

Group type: EXPERIMENTAL
Intervention: Rational emotive occupational health coaching (12 sessions)
Number of subjects: 158
Study: 32926825

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 0
Study: 35676589

Group type: EXPERIMENTAL
Intervention: Increase in ventricular size (VS)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Measures of perihematomal edema (PHE)
Number of subjects: 248
Study: 33758322

Group type: EXPERIMENTAL
Intervention: Smartphone-based pain management application
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no education provided)
Number of subjects: 128
Study: 34631134

Group type: EXPERIMENTAL
Intervention: Intervention group with smartphone app-based lifestyle intervention and conventional outpatient weight-management visits every 3 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group receiving only weight-management visits
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 28
Study: 35048226

Group type: EXPERIMENTAL
Intervention: 2L PEG + Ascorbic Acid
Number of subjects: 347

Group type: COMPARATOR
Intervention: 4L PEG
Number of subjects: 347
Study: 35101326

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 0
Study: 34218768

Group type: EXPERIMENTAL
Intervention: Pharmacist-led systematic medication review
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no pharmacist recommendations)
Number of subjects: 0
Study: 32017816

Group type: EXPERIMENTAL
Intervention: EEG Biofeedback therapy
Number of subjects: 0
Study: 34016485

Group type: EXPERIMENTAL
Intervention: Graded aerobic exercise (GAEx)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (standard rehabilitation only)
Number of subjects: 36
Study: 34686621

Group type: EXPERIMENTAL
Intervention: Positive stereotype
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Negative stereotype
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 36334689

Group type: EXPERIMENTAL
Intervention: Mobile web-based educational program (2-week duration)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Educational booklet
Number of subjects: 73
Study: 32796054

Group type: EXPERIMENTAL
Intervention: Computerised decision‐support software
Number of subjects: 46042
Study: 35708562

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation and Deep Breathing Exercises
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study: 34923994

Group type: EXPERIMENTAL
Intervention: Aprepitant (80 mg daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hydroxyzine (25 mg daily)
Number of subjects: 80
Study: 36055414

Group type: EXPERIMENTAL
Intervention: 50 mg caffeinated drink (CAF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 25
Study: 33446924

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (n = 32)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (n = 48)
Number of subjects: 80
Study: 34477122

Group type: EXPERIMENTAL
Intervention: Standard lymphadenectomy (SG)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Extended lymphadenectomy (EG)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Standard lymphadenectomy with postoperative adjuvant chemotherapy (SG)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Extended lymphadenectomy with postoperative adjuvant chemotherapy (EG)
Number of subjects: 212
Study: 34509972

Group type: EXPERIMENTAL
Intervention: Rehabilitation sessions (15 sessions of 40 minutes each)
Number of subjects: 55
Study: 35999684

Group type: EXPERIMENTAL
Intervention: 38 percent silver diamine fluoride (SDF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ACTIVA™
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Beautifil®
Number of subjects: 80

Group type: COMPARATOR
Intervention: Equia Forte®
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conditioner application
Number of subjects: 80
Study: 32395094

Group type: EXPERIMENTAL
Intervention: Swedish version of the Cultural Competence Assessment Instrument
Number of subjects: 312
Study: 33463088

Group type: EXPERIMENTAL
Intervention: Generic obeticholic acid (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Branded obeticholic acid (Ocaliva)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fasting conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fed conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Men
Number of subjects: 0
Study: 32573860

Group type: EXPERIMENTAL
Intervention: Tetrahydrocurcumin (THC) 40 mg/kg for 3 days
Number of subjects: 0
Study: 35968504

Group type: EXPERIMENTAL
Intervention: Cemented prostheses
Number of subjects: 60

Group type: COMPARATOR
Intervention: Biologic prostheses
Number of subjects: 60
Study: 32141126

Group type: EXPERIMENTAL
Intervention: Soluble dietary fiber (SDF) 20-g/d polydextrose
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (same EN solution without SDF)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Soluble dietary fiber (SDF)
Number of subjects: 49
Study: 36308982

Group type: EXPERIMENTAL
Intervention: NMR platform
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: LC-MS platform
Number of subjects: 1100
Study: 35222874

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 18G-PTC puncture needle therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Small needle-knife therapy
Number of subjects: 68
Study: 34488841

Group type: EXPERIMENTAL
Intervention: Early administration of colchicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32842965

Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping (DCM) intervention
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Managerial support and leadership approaches
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Understanding and engagement with the intervention
Number of subjects: 48
Study: 36942113

Group type: EXPERIMENTAL
Intervention: Tunica Albuginea Urethroplasty (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Buccal Mucosa Graft Urethroplasty (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 34986487

Group type: EXPERIMENTAL
Intervention: Computer-Based Cognitive Rehabilitation (CBCR) intervention group 1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Computer-Based Cognitive Rehabilitation (CBCR) intervention group 2
Number of subjects: 30

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 30
Study: 32598234

Group type: EXPERIMENTAL
Intervention: Overload throwing (5-, 6-, and 9-oz balls)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Extreme overload throwing (5-, 16-, and 32-oz balls)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Underload throwing (regulation 5-oz baseballs and 4- and 2-oz balls)
Number of subjects: 16
Study: 35195838

Group type: EXPERIMENTAL
Intervention: Radical vaginal hysterectomy with laparoscopic assistance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creation of a vaginal cuff before radical laparoscopic hysterectomy
Number of subjects: 0
Study: 34488085

Group type: EXPERIMENTAL
Intervention: GROUPS 4 HEALTH (G4H)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (before lockdown)
Number of subjects: 174
Study: 32608131

Group type: EXPERIMENTAL
Intervention: Interactive Computer‐assisted Client Assessment Survey (iCCAS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 50
Study: 33265083

Group type: EXPERIMENTAL
Intervention: HTPSG (horseshoe taping for patellar superior gliding)
Number of subjects: 28

Group type: COMPARATOR
Intervention: HTPIG (horseshoe taping for patellar inferior gliding)
Number of subjects: 28